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FIGURE! 
Sequence ID No 1: DNA Sequence ofpromoter clone PFit-UAS-lX, 376-hp, (coordinat.e in respect oft.ranscription start site, 
TSS, -352 to +24) 
l,GTTTTTl',CT TCGGACAGTC Al,Ai\ATGAGT TTAl-,CTTCTC l\GCCGl',GGTA AAACAAGl-\AA Tl\TGCTTACG TCTACAGAGG 
GATTTCTCTG AAGATCATGT TTGCCAGCTA TGCGAACAAT CATCGGGAGA TCTTGAGCCA ATCAl-\.AGAGG AGTGATGTAG 
ACCTAAAGCA ATAATGGAGC CATGACGTAA GGGCTTACGC CCATACGAAA TAATTAAAGG CTGATGTGAC CTGTCGGTCT 
CTCAGAl,CCT TTI-\.CTTTTTJ\ TATTTGGCGT GTATTTTTAA ATTTCCACGG CAATG.A_CGAT GTGACCTGTG CATCCGCTTT 
GCCTATAAJI.T l\.AGTTTTAGT TTGTATTG.l' .. T CGAC]I.CGATC GAGl-\.AGI-\.CAC GGCCAT 
Sequence ID No 2: DNA Sequence of promoter clone PFit-UAS-2X, 686-bp; coordinate in respect of transcription start site 
(TSS) -662 to +24 
AGTTTTTACT TCGGACl\_GTC AAAAATGAGT TTAI>.CTTCTC l-\.GCCGAGGTA AAACI>.AGAN\ TATGCTT.Z-\.CG TCTACI>.GAGG 
GA'l"l"l'CTC'I'G AAGATCA'l'G'l' 'l'GCCAGCTA'I' GCGAACAA'l'C A'l'CGGGAGA'I' CTTGAGCCAA 'l'CAAAGAGGA GTGA'I'G'l'AGA 
CC'I'AAAGCa~ T&~TGGAGCC ATGACGTl\AG GGCTTACGCC CATACGAa~T AATTAAAGGC TGATGTGACC TGTCGGTCTC 
TCAGAACCTT TACTTTTTAT ATTTGGCGTG TATTTTTAAA TTTCCACGGC AATGACGAGG TGACCCAACG AGTTTTTACT 
'l'CGGACAG'I'C AAAAA'l'GAG'l' 'l"l'AACTTC'I'C AGCCGAGG'l'A AAACAAGllli1\ TATGC'l"l'ACC TC'l'ACAGAGG GATTTC'l'C'l'C 
AAGATCATGT TTGCCAGCAA TGCGAACAAT CATCGGGAGA TCCTGAGCCA ATCAAAGAGG AGTGATGTAG ACCTAAAGCA 
ATAATGGAGC CATGACGTAA GGGCTTACGC CCATACGAAA TAATTAAAGG CTGATGTGAC CTGTCGGTCT CTCAGAACCT 
'I''I'AC'l''l''l''l"l'A 'l'A'l''l'TGGCG'I' G'I'A'l'T'l"l'TAA A'l'T'l'CCACGG CAA'l'GACGA'l' G'l'GGCCTG'I'G Cl\TCCGC'l"l'T CCC'l'ATAAAT 
l\_~GTTTTAGT TTGTATTGAT CGACACGATC GAGA]I_GACAC GGCCAT 
Sequence ID No 3: DNA Sequence of promoter clone FSgt-PFlt, 593-bp, coordinate in respect of transcription start site (TSS): 
-569 to +24 
TTACAGTAAG li..ACTGATAAC AAAAATTTTA CTTATTTCCT TAGAATTAAT CTTAAAGGTG ATAGTAAACA AGGACGATTA 
GTCCGTTGGC l\.AA]I_TTGGTT Cl\_GCAGGT.~'I' CAAT'I''I'GATG TCGl\.AC.~TC'I' TGAAGG'I'G'I'A AAAAACGTTT TAGCAGl\_TTG 
CCTCACGAGA GATTTTAATC CTTAAAAACG TAAGCCCTGll. CGTATGATTT CCCAACGAGT TTTTACTTCG GACAGTC&".A 
l\.ATG.~GTTTA ACTTCTCAGC CGAGGTa~ Cl\AGAAATAT GCTT]I.CGTCT ACAGAGGGli.T TTCTCTGAAG ATCl\_TGTTTG 
CCAGCAATGC GAACAATCAT CGGGAGATCC TGAGCCAATC AAAGAGGAGT GATGTAGACC TAAAGCAATA ATGGAGCCAT 
GACG'l'AAGGG CTTACGCCCA 'l'ACGAAATAA T"I'AAAGGC'l'G A'l'G'l'GACCTG TCGGTCTC'l'C AGAACCT'l'TA C'I'TTT"I'Nl'AT 
TTGGCGTGTA TTTTTi-\.AATT TCCACGGCAA TGACGATGTG GCCTGTGCAT CCGCTTTGCC TATAAATAAG TTTTAGTTTG 
TATTGATCGA CACGATCGAG AAGii.CACCGC CAT 
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FIGURE9 
Sequence ID No 4: DNA Sequence of promoter clone MSgt-PFlt 
CGGTAAAACA GGTGATTACT AAATTTAGTA TTTATCTAAC CCCTGTTTGT TTTACAGTCA GGACAGATAA 
TGTAAATCTT TTAAAAGGAT TTATGAATAA AAAGATTACT GGTGACAGTA AACAGGGAAG GCTAATAAGA 
TGGCAAATGT GGTTTTCACA TTACACCTTT AAGGTGGACC ACCTAAAAGG AGAACAAAAT GTGCTGGCTG 
ATTATCTCAC CAGAGAATTC CCCCAACGAG TTTTTACTTC GGACAGTCAA AAATGAGTTT AACTTCTCAG 
CCGAGGTAAA ACAAGAAATA TGCTTACGTC TACAGAGGGA TTTCTCTGAA GATCATGTTT GCCAGCAATG 
CGAACAATCA TCGGGAGATC CTGAGCCAAT CAAAGAGGAG TGATGTAGAC CTAAAGCAAT AATGGAGCCA 
TGACGTAAGG GCTTACGCCC ATACGAAATA ATTAAAGGCT GATGTGACCT GTCGGTCTCT CAGAACCTTT 
ACTTTTTATA TTTGGCGTGT ATTTTTAAAT TTCCACGGCA ATGACGATGT GGCCTGTGCA TCCGCTTTGC 
CTATAAATAA GTTTTAGTTT GTATTGATCG ACACGATCGA GAAGACACGG CCAT 
Sequence ID No 5: DNA Sequence of PFlt promoter fragment 
AGTTTTTACT TCGGACAGTC AAAAATGAGT TTAACTTCTC AGCCGAGGTA AAACAAGAAA TATGCTTACG 
TCTACAGAGG GATTTCTCTG AAGATCATGT TTGCCAGCTA TGCGAACAAT CATCGGGAGA TCTTGAGCCA 
ATCAAAGAGG AGTGATGTAG ACCTAAAGCA ATAATGGAGC CATGACGTAA GGGCTTACGC CCATACGAAA 
TAATTAAAGG CTGATGTGAC CTGTCGGTCT CTCAGAACCT TTACTTTTTA TATTTGGCGT GTATTTTTAA 
ATTTCCACGG CAATGACGAT GTGACCTGTG CATCCGCTTT GCCTATAAAT AAGTTTTAGT TTGTATTGAT 
CGACACGATC GAG&~GACAC GGCCAT 
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GUS Activity in transgenic tobacco lines 
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1 
UNIQUE NUCLEIC ACID PROMOTER 
FORMED FROM TWO OR MORE 
PROMOTER SEQUENCES 
CROSS-REFERENCE TO RELATED 
APPLICATION 
2 
bp between two promoters often lead to gene silencing in 
transgenic plants (Flavell, 1994). 
SUMMARY OF THE INVENTION 
The present invention relates to unique, non-naturally (i.e. 
not found in nature) occurring promoters produced from frag-
ments or full sequences of promoters from genomes ofPF!t-
UAS-2X and FSgt-PF!t from Peanut Chlortic Streak Virus 
This application claims the benefit of U.S. Provisional 
Patent Application No. 61/819,017, filed May 3, 2013, herein 
incorporated by reference. 
FIELD OF THE INVENTION 
The present application relates to DNA promoters for gene 
expression and in particular unique promoters formed from 
DNA fragments. Advantageously, the present promoter DNA 
has enhanced activity in terms of gene expression. The 
present invention also relates to methods for producing 
unique promoters. 
10 (PC1SV) and Figwort Mosaic Virus (FMV) as well as MSgt-
PF!t from genomes of the Peanut Chlortic Streak Virus 
(PC1SV) and Mirabilis Mosaic Virus (MMV). In addition, 
promoters in accordance with the disclosure include combi-
nations of the aforementioned fragments. The present inven-
15 tion also relates to method for producing aforementioned 
non-naturally occurring promoters. 
In accordance with this disclosure, an engineered genetic 
promoter DNA fragments obtained from Peanut Chlortic 
Streak Virus (PC1SV) and Figwort Mosaic Virus (FMV) 
BACKGROUND OF THE INVENTION 
The key genetic regulator, promoter, usually determines 
the ultimate fate of gene transcription. The structure of 
eukaryotic promoter is modular comprising a distal upstream 
activating sequence (UAS) and a proximal core promoter 
containing TATA element. Both distal and proximal regions 
are embedded with a number of cis elements which acts as the 
binding sites of different transcription factors and transcrip-
tion binding proteins (TBPs) while RNA polymerase binds to 
the proximity ofTATA box. The combinatorial/spatial inter-
actions between cis and trans factor along with the cross talk 
between the proximal and distal part of promoter usually 
determines the functional characteristics of the promoter and 
regulate the gene transcription (Goodrich and Tjian, 2010; 
Lee and Young, 2000). Based upon these factors, redesigning 
20 includes promoters (i) PF!t-UAS-2X: developed by inserting 
an additional copy of a sub genomic transcript promoter 
fragment ( -352 to -49) of Peanut Chlortic Streak Virus 
(PC1SV-Sgt) to the 5' end of TATA containing PC1SV-Flt 
promoter fragment between coordinates -352 to +24 and (ii) 
25 FSgt-PF!t: constructed by ligating a sub genomic transcript 
promoter fragment ( -270 to -60) of Figwort Mosaic Virus 
(FMV-Sgt) to the 5' end of a PC1SV-Flt promoter fragment 
between coordinates -352 to +24. 
This disclosure includes a technique for obtaining genetic 
30 promoters DNA fragments from Figwort Mosaic Virus 
(FMV) comprising isolating FMV Sgt promoters plus UAS 
domain of full length transcript of Peanut Chlortic Streak 
Virus (PC1SV). Further, this disclosure includes methods of 
assaying promoter activities subjecting to the isolation PF!t-
35 UAS-2X and FSgt-PF!t promoters of Peanut Chlortic Streak 
Virus (PC1SV) and Figwort Mosaic Virus (FMV) Sgt pro-
moters to the step of molecular cloning and determining the 
activities of the promoters both in transient and transgenic 
of promoter structure by genetic manipulations could be pos-
sible to develop a better promoter with altered cis-profiles/ 
cis-arrangements. Such 'tailor-promoter' usually holds better 
promise for developing plant of interest in comparison to the 40 
native promoter. Exchanging/swapping/shuffling the proxi-
mal and distal domains among different native (plant/animal) 
promoter sequences, one can develop unique recombinant 
promoter-module that manifest functional properties com-
bining the features of both donating and receiving promoters 45 
(Venter and Botha, 2010; Bhullar eta!., 2003; Venter, 2007). 
Several engineered/modified promoters were developed in 
recent past (Comai eta!., 1990, Ni eta!., 1995; Lee eta!., 
2007; Rushton eta!., 2002; Venter, 2007). The present inven-
tors have developed several useful plant promoters using both 50 
full-length transcript (Fit-) and sub-genomic transcript (Sgt-) 
promoters from different members of pararetrovirus (Kumar 
eta!., 2011; Ranjan eta!., 2012; Patro eta!., 2012, Kumar et 
a!., 2012). Unfortunately, the availability of such engineered 
promoters is not sufficient to meet their current demand in 55 
plant molecular biology and there is a constant shortage of 
such promoter in plant molecular biology. 
Again, in eukaryotes a single gene requires a promoter for 
its expression. Therefore, during gene stacking or gene pyra-
miding, one needs to use multiple numbers of heterologous 60 
promoters for expression multiple numbers of genes. There is 
possibility of promoter sequence homology based genetic 
rearrangement/recombination in case of repeated use of same 
promoter for expressing multiple number of gene in plant 
cell. In such cases, use of different heterologous promoters 65 
could be advantageous over multiple use of same promoter as 
it was documented that homologous sequences, more than 90 
assay. 
Further, the disclosure provides a technique for enhancing 
the activity of genetic promoter fragment. 
The engineered promoters include PF!t-UAS-2X and 
FSgt-PF!t withhigherefficacy of successful gene transforma-
tion in plant. The 305 bp long UAS domain of full-length 
transcript promoter fragment ( -353 to -49) of Peanut Chlo-
rtic Streak Virus (PC1SV-Flt) was inserted at the 5' end of 
TATA containing PC1SV-Flt promoter fragment ( -352 to 
+24) to develop 686 bp long full length transcript promoter 
fragment of Peanut Chlortic Streak Virus with double 
enhancer domain PF!t-UAS-2X. Likewise, a 211 bp long 
UAS domain ofFigwort Mosaic Virus sub genomic transcript 
promoter fragment ( -270 to -60) was ligated to the 5' end of 
a PC1SV-Flt promoter fragment between coordinates -352 to 
+24 to develop a recombinant promoter of 593 bp long FSgt-
PF!t. 
The inventors have evaluated the transient activities of 
these two newly derived promoter fragments; PF!t-UAS-2X 
and FSgt-PF!t in tobacco protoplast system along with their 
transgenic activities were tested in transgenic tobacco plants. 
The inventors have compared their transient and transgenic 
activities with that of the CaMV35S promoter and also 
observed positive correlation among the GUS activities of 
transgenic tobacco plant expressing PF!t-UAS-2X and FSgt-
PF!t promoter separately with the accumulation level of cor-
responding uidA transcript in transgenic plant. Histochemi-
cal staining of different parts of transgenic plant expressing 
PF!t-UAS-2X and FSgt-PF!t promoter construct individually 
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confirms that they are semi-constitutive in nature. Taken all 
together, the newly derived pararetrovirus based recombinant 
sub-genomic transcript promoters; PFlt-UAS-2X and FSgt-
PFlt are additional molecular tools for transgenic plant devel-
opment with much higher efficacy than the CaMV35S pro- 5 
mater. Thus they could become potential candidate-promoter 
for multi-gene based molecular pharming and plant meta-
bolic engineering. 
In addition, the present invention relates to an engineered 
genetic promoter DNA fragment obtained from Peanut Chlo- 10 
rtic Streak Virus (PClSV) and Mirabilis Mosaic Virus 
(MMV) wherein the promoter, MSgt-PFlt, constructed by 
ligating a sub genomic transcript promoter fragment ( -356 to 
-125) ofMirabilis Mosaic Virus (MMV-Sgt) to the 5' end of 15 
a PClSV-Flt promoter fragment between coordinates -352 to 
+24 (PFlt-UAS-lX). 
The present invention also relates to a technique foro btain-
ing genetic promoter DNA fragment from Mirabilis Mosaic 
Virus (MMV) comprising isolating MMV Sgt promoter plus 20 
UAS domain of full-length transcript of Peanut Chlortic 
Streak Virus (PC! SV). This invention also relates to methods 
of assaying promoter activities subjecting isolation of the 
MSgt-PFlt promoter from Peanut Chlortic Streak Virus 
(PC! SV) and Mirabilis Mosaic Virus (MMV) Sgt promoters 25 
to the steps of molecular cloning and determining the activi-
ties of the promoter both in transient and transgenic assay. 
Further, the present invention relates to expression of 
immunological gene and immunological gene of interest in 
plant protoplast using engineered promoters, e.g. PFlt-UAS- 30 
2X and FSgt-PFlt and MSgt-PFlt. 
As will be clear from the following discussion, the present 
promoters allow for enhanced gene expression in plants. 
The engineered promoter namely, MSgt-PFlt with com- 35 
plete heterogenous sequences and possess almost equal tran-
scriptional activity to that of the most widely used promoter, 
the CaMV35S. A 232 bp long UAS domain of Mirabilis 
Mosaic Virus sub-genomic transcript promoter fragment 
(-356 to -125) was ligated to the 5' end of a PClSV-Flt 40 
promoter fragment between coordinates -352 to +24 to 
develop the recombinant promoter MSgt-PFlt (614 bp). The 
transient activities of this newly derived promoter fragment 
were evaluated; MSgt-PFlt in tobacco protoplast system, 
along with transgenic activities tobacco plants. Furthermore, 45 
the inventors compared its transient and transgenic activities 
with that of the CaMV35S promoter. In this regard, the inven-
tors have observed positive correlation among the average 
GUS activities obtained from transgenic tobacco plant 
expressing MSgt-PFlt with the accumulation level of corre- 50 
sponding uidA transcripts in transgenic plant. Histochemical 
staining of different parts of transgenic plant expressing the 
MSgt-PFlt promoter construct confirms that it is a semi-
constitutive promoter. Taken all together, the newly derived 
pararetrovirus based recombinant sub-genomic transcript 55 
promoter; MSgt-PFlt can be additional molecular tool for 
transgenic plant development with equivalent efficacy with 
that of the CaMV35S promoter. The recombinant promoter, 
MSgt-PFlt, reported in the present invention could be used as 
an alternative of the CaMV35S in plant biology; thus, it could 60 
become a potential candidate-promoter for multi-gene based 
molecular pharming and plant metabolic engineering. 
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single enhancer domain of sub-genomic transcript ofFigwort 
Mosaic Virus ligated to the full length transcript of Peanut 
Chlortic Streak Virus. 
FIG. 2 includes schematic diagrams of gene expression 
cassettes for Pft-UAS-lX (A), PFit-UAS-2X (B) and FSgt-
PFlt (C) promoters respectively GUS-13 glucuronidase; 
Kanr- Kanamycin resistant gene. 
FIG. 3 shows transient activities ofCaMV3 5S, PFlt-UAS-
lX, PFlt-UAS-2X and FSgt-PFlt promoters in tobacco pro-
toplast system coupled to GUS reporter gene. 
FIG. 4 shows green florescence obtained from ImaGene 
Green treated transformed protoplast expressing CaMV 35S, 
PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFit (coupled to GUS 
reporter gene). Panel!, Panel2 and Panel3 represent bright 
field images, green fluorescence images and superimposed 
images respectively obtained from transformed protoplast 
expressing above promoter constructs. 
FIG. 5 shows the transgenic promoter activities of 
CaMV35S, PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFlt pro-
moter coupled to GUS reporter gene. The data presented are 
means of five independent experiments with respective stan-
dard deviation. For each construct, eight to ten independent 
transgenic lines developed. Untransformed control (Wild), 
tissue extract from wild-type N. tabacum cv. SamsunNN. 
FIG. 6 shows real-time PCR based quantitative estimation 
of GUS transcripts accumulation in transgenic plants 
expressing GUS under the control of CaMV35S, PFlt-UAS-
lX, PFit-UAS-2X and FSgt-PFlt promoters. The data pre-
sented as an average fold differences of GUS transcript with 
corresponding standard deviation of three independent 
experiments. Each bar represents 4.2 fold difference ofuidA 
level in transgenic plants expressing above promoter con-
structs independently considering the accumulation of 
mRNA level by CaMV35S promoter a value of 1. 
FIG. 7 shows expression of mammalian Interleukin 2 (IL-
2) protein in tobacco protoplast under control of PFlt-UAS-
lX, PFlt-UAS-2X and FSgt-PFlt promoter. 
FIG. 8 shows images ofX-Gluc staining (Histochemical 
analysis) leaf petiole cross section of 21 days old transgenic 
plants expressing GUS under the control ofCaMV 35S, PFlt-
UAS-2X and FSgt-PFlt promoters (details of assay discussed 
under Example 3). 
FIG. 9 shows the DNA sequences for SEQ ID NOS: 4 and 
5, in which SEQ ID NO: 4 is the DNA sequence of promoter 
clone MSgt-PFlt, in accordance with the present invention 
(i.e. the UAS domain of full length transcript promoter from 
Peanut Chlortic Streak Virus; PFlt promoter fragment and the 
newly derived promoter MSgt-PFlt) and SEQ ID NO: 5 is the 
DNA sequence of a PFlt promoter fragment, in accordance 
with the present invention. 
FIG. 10 shows schematic diagrams of gene expression 
cassettes carrying PFlt promoter fragment (A) and MSgt-PFit 
(B) promoters respectively coupled to GUS reporter gene; 
GUS-~ glucuronidase; Kanr- Kanamycin resistant gene. 
FIG. 11 shows transient activities ofCaMV35S, PFlt pro-
moter fragment and MSgt-PFlt promoters in tobacco proto-
plast system coupled to GUS reporter gene. 
FIG. 12 shows green florescence obtained from ImaGene 
Green treated transformed protoplast expressing correspond-
ing promoter as mentioned above. Panel!, Panel 2 and Panel 
3 represent bright field images, green fluorescence images 
and superimposed images respectively obtained from trans-
formed protoplast expressing above promoter constructs. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG.1 shows the DNA sequences, SEQ ID NOS: 1-3, of the 
promoter PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFlt with 
FIG. 13 shows the transgenic promoter activities of 
65 CaMV35S, PFlt and MSgt-PFlt promoter coupled to GUS 
reporter gene. The data represented are means of five inde-
pendent experiments with respective standard deviation. For 
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each construct, eight to ten independent transgenic lines 
developed. Untransformed control (Wild), tissue extract from 
wild-type Nicotiana tabacum cv. SamsunNN. 
FIG. 14 shows real-time PCR based quantitative estima-
tion of GUS transcript accumulation in transgenic plants 5 
expressing GUS under the control of CaMV35S, PF!t pro-
moter fragment and MSgt-PFit promoters. The data pre-
sented as an average fold differences of GUS transcript with 
corresponding standard deviation of three independent 
experiments. Each bar represents fold difference of uidA 
10 level in transgenic plants expressing above promoter con-
structs independently considering the accumulation of GUS-
mRNA level by CaMV3 5S promoter a value of 1. 
FIG. 15 shows expression of mammalian Interleuk:in-2 
(IL-2) protein in tobacco protoplast under control ofCaMV 
35S, PF!t and MSgt-PF!t promoter. 
FIG. 16 shows images ofX-Gluc staining (Histochemical 
analysis) leaf petiole cross section of 21 days old transgenic 
plants expressing GUS under the control of CaMV35S, PF!t 
and MSgt-PF!t promoters, in accordance with the present 
disclosure, including the assay of Example 7. 
FIG. 17 is a graphing showing average GUS activities 
(nmole MU/min/mg protein) ofCaMV35S, PF!t, PFLt-UAS-
2X, FSgt-PF!t and MSgt-PF!t obtained from transformed 
Arabi do psis protoplast individually with corresponding stan-
dard deviations. 
FIG. 18 are graphs showing transient GUS activities assay 
ofCaMV35S, PF!t, PFLt-UAS-2X, FSgt-PF!t andMSgt-PF!t 
promoter constructs in three different plants system namely 
Petunia hybrida, Spinacea oleracia and Solanum lycopersi-
15 
20 
25 
cum, respectively. 30 
FIG. 19 are light microscope images/stains showing dif-
ferential expression of the GUS reporter gene under control of 
CaMV35S, CaMV35S2, PF!t, PF!t-UAS-2X, FSgt-PF!t and 
MSgt-PF!t promoter constructs during different time-point of 
seed germination, which are light microscopy images of 35 
X-gluc treated whole seedlings (21 days) of untransformed 
control and transgenic tobacco plant expressing CaMV35S, 
CaMV35S2, PF!t, PF!t-UAS-2X, FSgt-PF!t and MSgt-PF!t 
promoters coupled to GUS reporter gene. 
FIG. 20 are micrographs for CLSM based comparative 40 
analysis of the relative GUS expression under control of 
CaMV35S, PF!t, PF!t-UAS-2X, FSgt-PF!t and MSgt-PF!t 
promoter in transgenic floral organs, which are superimposed 
(bright field and fluorescent) images of ImaGene Green™ 
treated cross-sections of transgenic floral organ (style, ovary 45 
and filament) expressing the GUS gene under respective pro-
moter construct. 
FIG. 21 is a graph showing intensities of Green fluores-
cence obtained from 50/60 regions of interest (ROis) of trans-
genic floral organs expressing above promoter construct. The 50 
average intensity was determined for respective floral organs/ 
tissues and presented. 
FIG. 22 is a graph showing average GUS activities (in 
nmole MU/min/mg protein) from the root, leaf and stem of 
transgenic tobacco seedling (21 days old) expressing GUS 55 
under the control of the above promoter constructs. 
FIG. 23 are graphs showing spatial distribution of GUS 
expression (in nmole MU/min/mg protein) from the root, leaf 
and stem of 21 days old transgenic tobacco seedlings driven 
by CaMV35S, CaMV35S2, PF!t, PF!t-UAS-2X, FSgt-PF!t 60 
and MSgt-PF!t promoter constructs under 150 f.LM Salicylic 
Acid and Abscisic acid treatment. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention provides a strategy for construction 
of modified promoters; PFit-UAS-2X and FSgt-PF!t employ-
65 
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ing prpmoter sequences from Peanut Chlortic Streak Virus 
and Figwort mosaic virus. This invention also relates to a 
method of using the promoters in plant and protoplast system 
for expression of any trans gene. Features include: 
Molecular cloning of PF!t-UAS-lX (PClSV genomic 
coordinate 5725 to 6100, PClSV-Flt promoter coordi-
nates -352 to +24 from TSS) from Peanut Chlortic 
Streak Virus full-length transcript. 
Molecular cloning of upstream activation sequence 
(PClSV genomic coordinates 5725 to 6100, PClSV 
promoter coordinates -352 to -49) from Peanut Chlortic 
Streak Virus full-length transcript (PF!t-UAS-1 X) pro-
moter. 
Molecular cloning of domain containing upstream activat-
ing sequence, from Figwort mosaic virus sub-genomic 
transcript (FMV-Sgt) promoter. (UAS from FMV 
genomic coordinates 5163 to 5363; FMV-Sgt promoter 
coordinates -270 to -60). 
Construction of modified promoter (PF!t-UAS-2X) with 
double enhancer domain by adding the upstream acti-
vating sequence (promoter coordinates -352 to -49) to 
the 5' end of the core promoter domain ( -352 to +24) of 
PClSV Fit. 
Construction of chimeric promoter (FPF!t-UAS-lX) by 
intermolecular hybridization by ligating the upstream 
activating sequence ( -270 to -60) of Figwort mosaic 
virus to the core promoter domain (-352 to +24) of 
PClSV Fit. 
The efficacies of the modified promoters; (PF!t-UAS-2X) 
and chimeric promoter (FSgt-PF!t-UAS-lX) coupled to 
GUS reporter gene was tested by transient (in tobacco 
protoplast system) and transgenic (in tobacco plant) 
assays. 
The modified PF!t-UAS-2X and chimeric promoters FSgt-
PF!t were found to be stronger ( 4 to 6 fold) compared to 
the CaMV35S promoter widely used in plant biology. 
The present invention also relates to a strategy for construc-
tion of modified promoter; MSgt-PF!t employing promoter 
sequences from Peanut Chlortic Streak Virus and Mirabilis 
Mosaic Virus. This invention also describes the method of 
using the said promoters in plant and protoplast system for 
expression of any trans gene. 
Additionally features include: 
Molecular cloning of PF!t promoter fragment (PClSV 
genomic coordinate 5725 to 6101, PC! SV-Flt promoter 
coordinates -352 to +24 from TSS) from Peanut Chlo-
rtic Streak Virus full-length transcript. 
Molecular cloning of domain containing upstream activat-
ing sequence, from Mirabilis Mosaic Virus sub-genomic 
transcript (MMV-Sgt) promoter. (UAS from MMV 
genomic coordinates; MMV-Sgt promoter coordinates 
-356 to -125). 
Construction of recombinant promoter (MSgt-PF!t) by 
intermolecular hybridization of the upstream activating 
sequence (-356 to -125) ofMirabilis Mosaic Virus to 
the core promoter domain ( -352 to +24) of PCISV Fit. 
The efficacies of the modified promoter (MSgt-PF!t) 
coupled to GUS reporter gene was tested by transient (in 
tobacco protoplast system) and transgenic (in tobacco 
plant) assays. 
The modified promoter, MSgt-PF!t was found to compa-
rable/equivalent to the CaMV35S promoter, most 
widely used promoter in plant biology. 
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EXAMPLES 
The present invention will now be described with reference 
to the following non-limiting examples and experiments. 
Example 1 
Construction of Vector Containing Modified and 
Chimeric Promoter 
Ia) Cloning of Modified and Chimeric Promoter 
The 376 bp long PFlt-UAS-lX promoter fragment 
(PClSV-FLt; SEQ ID NO: 1, FIG. 1) ( -352 to +24), 305 bp 
long PFlt-UAS-2X promoter fragment ( -353 to -49) and211 
by long FMV-Sgt-UAS promoter fragment ( -270 to -60) 
were PCR amplified as described by Dey and Maiti, (1999) 
using specific primer pairs containing the appropriate 
sequence to generate EcoRI and Hindi sites at the 5' end and 
Smai and Hindiii sites at the 3' end using corresponding 
genomic DNA clone. PCR-amplified fragments were 
restricted with EcoRI and Hindiii endonucleases and gel 
purified. Digested promoter fragments were cloned into the 
corresponding sites of pUC 119 vector; the resulting plasmids 
were designated as pUCPFlt-UAS-lX, pUCPFlt-UAS-lX-
UAS and pUCFSgt-UAS. All of these plasmids were sub-
jected to automated sequencing. The PFlt-UAS-lX promoter 
fragment was isolated from pUCPFlt-UAS-lX clone as 
Hincii-Hindiii fragment; and it was then inserted into the 
Smai andHindiii sites ofpUCPFlt-UAS-lX-UAS clone and 
the resulting plasmid was designated as PFlt-UAS-2X. Simi-
larly, the PFlt-UAS-lX promoter fragment (376-bp) was iso-
lated from pUCPFlt-UAS-lX clone as Hincii-Hindiii frag-
ment; and it was then inserted into the Smai and Hindiii sites 
of pUCFSgt-UAS clone. The resulting chimeric promoter 
clone was designated as FSgt-PFlt. The plasmids were 
sequenced (Sanger et a!., 1977) and the sequence of this 
promoter is presented in FIG. 1, SEQ ID NO: 3. 
1 b) Cloning of PFlt-UAS-2X and FSgt-PFlt Promoter 
Sequence in the Protoplast Expression Vector p UCPMAGUS 
The PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFlt promoter 
was isolated as EcoRI and Hindiii fragment from sequencing 
vectors pUCPFlt-UAS-lX, pUCPFlt-UAS-2X and pUCF-
Sgt-PFlt respectively and sub-cloned into the corresponding 
sites of the protoplast expression vector coupled to GUS 
reporter gene pUCPMAGUS (Dey andMaiti 1999) by replac-
ing the CaMV35S promoter and the resulting clones were 
designated as pUPPFlt-UAS-lX, pUPPFlt-UAS-2X and 
pUPFSgt-PFlt respectively. 
2a) Cloning oflnterleukin-2 (IL-2) 
The 500 bp long IL-2 was PCR amplified using specific 
primer sequence to incorporate Xho I and Xbai in the 5' and 
3' end of the amplified gene respectively. It was then cloned 
into the corresponding sites of pUC119 containing PFlt-
UAS-lX, PFlt-UAS-2X and FSgt-PFlt promoters and the 
resulting plasmid was named as IL-2pUCPFlt-UAS-lX, 
IL-2pUCPFlt-UAS-2 and IL-2pUCF Sgt-PFlt respectively. 
8 
were designated as IL-2pUPPFlt-UAS-lX, IL-2pUPPFlt-
UAS-2X and IL-2pUPFSgt-PFlt respectively. 
Example 2 
Transient Assay of the Promoters in Tobacco 
Protoplast System 
Protoplasts from tobacco cell suspension cultures (Xanthi 
10 
'Brad') were purified on 20% sucrose gradient after being 
digested by cellulase (Sigma Cat #C0615-l G) and pectinase 
(Sigma Cat #P4300-5 KU). Electroporation of protoplasts 
with supercoiled DNA containing GUS reporter genes were 
conducted as described earlier (Kumar eta!., 2012) by using 
the GenePulser II Apparatus (BioRad) with the Capacitance 
15 Extender II (Model165-2107). In brief, an aliquot of750-fll 
containing 2x106 protoplasts in an electroporation cuvette 
(0.4 em electrode gap) was electroporated (200 V used for 
charging 965-f.LF capacitance for 40-50 ms) with 5-f.lg of each 
following promoter constructs CaMV35S, pUPPFlt-UAS-
20 IX pUPPFlt-UAS-2X and pUPFSgt-PFlt. 
Transformed protoplast expressing CaMV35S, PFlt-UAS-
lX, PFlt-UAS-2X and FSgt-PFlt were incubated in 1 mM 
MUG (4-methyl-umbelliferyl-D-glucuronide) at 37° C. for 
30 min. to produce MU (7-Hydroxy-4-Methylcoumarin) for 
25 biochemical GUS estimation (Jefferson eta!., 1987) and the 
result were presented in FIG. 3. pUPPFlt-UAS-2XGUS and 
pUPFSgt-PFlt-UAS-lXGUS promoter showed 2.25 and 3.6 
times stronger activity compared to CaMV35S promoter in 
tobacco protoplast system. 
To confirm the reporter gene (GUS) expression, the trans-
30 formed protoplast expressing CaMV35S, PFlt-UAS-lX, 
PFlt-UAS-2X and FSgt-PFlt promoter were incubated indi-
vidually, in 55 mM ImaGene Green™ C12FDG!cU substrate 
(ImaGene Green™ GUS Gene Expression Kit; Invitrogen, 
Oregon, USA) as per kit's instructions and kept under 
35 vacuum infiltration for 10 min initially and then incubated at 
room temperature for 2-3 hrs in the dark. Fluorescence 
images of protoplast the transform with CaMV35S, PFlt-
UAS-lX, PFlt-UAS-2X and FSgt-PFlt promoter constructs 
were captured using a CLSM (TCS SP5; Leica, D 68165 
40 Mannheim, Germany). The captured fluorescence images 
were presented in FIG. 4. For estimating GUS, the ImaGene 
Green™ treated transformed protoplast were excited with 
488 diode laser (use of 495 nm UV laser may be more appro-
priate) and fluorescence emissions were collected between 
45 500 and 515 nm with detector (PMT) gain set at 1150V. GUS 
localizations at cellular/tissue level were detected by green 
fluorescent lipophilic fluorescein derivative (5-dodecanoy-
laminofluorescein). 
ELISA of Protoplast Derived IL-2 Protein Driven by PFlt-
UAS-lX PFlt-UAS-2X and FSgt-PFlt Promoter Sequence 
50 A 100 fll PBS containing 10 flg of protein extracts from 
protoplasts transformed with each ofiL-2pUPPFlt-UAS-lX, 
IL-2pUPPFlt-UAS-2X and IL-2pUPFSgt-PFlt constructs 
were coated into a 96 well ELISA plate. The concentration of 
protoplast derived IL-2 was estimated following indirect 
55 ELISA protocol (Vazquez et a!., 1996) using an anti-IL2 
antibody (Santacruz, USA) and the result obtained is pre-
sented in FIG. 7. 
2b) Cloning of IL-2PFlt-UAS-lX, IL-2PFlt-UAS-2X and 
IL-2FSgt-PFlt in the Protoplast Expression Vector p 60 
UCPMAGUS 
Example 3 
Construction of Plant Expression Vectors with 
PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFlt 
Promoters, Plant Transformation and Analysis of 
Transgenic Plants 
The IL-2 gene was isolated as Xhoi and Xbai fragment 
from sequencing vectors IL-2pUCPFlt-UAS-lX, IL-2pUCP-
Flt-UAS-2X and IL-2pUCFSgt-PFlt respectively and sub-
cloned into the corresponding sites of the protoplast expres- 65 
sian vector pUCPMAGUS (Dey and Maiti 1999) by 
replacing the CaMV35S promoter and the resulting clones 
Promoter fragment PFlt-UAS-lX (376 bp) (SEQ ID NO: 
1), PFlt-UAS-2X (686 bp) (SEQ ID NO: 2) and FSgt-PFlt 
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(593 bp) (SEQ ID NO: 3) (See FIG. 1) were purified from 
corresponding pUC-clones and were cloned into the plant 
expression vector pKYLX71GUS (Schardl eta!., 1987; Dey 
and Maiti 1999) at its unique EcoRI and Hindiii sites that 
flank the promoter by replacing the CaMV35S promoter. 
Resulting plant expression vectors were designated pKPFlt-
UAS-1X, pKPFlt-UAS-2X and pKFSgt-PFlt respectively. 
10 
10 
GUS staining buffer (1 00 mM NaP04 , 0.5 mM K3 [Fe(CN)6 , 
0.5 mM K4 [Fe(CN)6], 10 mM EDTA, 1 mg/ml 5-bromo-4-
chloro-3-indolyl-b-D-glucuronide (X-glue), vacuum infil-
trated under pressure for 10 min followed by incubation at 3 7° 
C. for overnight. Samples were then washed and fixed (in 
50% ethanol, 7% acetic acid). The intensity of color devel-
opment in different tissues was monitored and photographs 
were taken by using inverted Leica DM LS2 microscope at 4x 
magnification (FIG. 8). 
Example 4 
Reactions of qRT-PCR were performed as described earlier 
by Kumar et a!., 2011. The eDNA was synthesized using 
RNA (DNasei treated) isolated from transgenic tobacco 
plants expressing CaMV35S, PFlt-UAS-1X, PFlt-UAS-2X 
and FSgt-PFlt promoter constructs individually using eDNA 
synthesis Kit (Fermentas, USA). The qRT-PCR for relative 
Promoter constructs namely pKYLX-GUS (containing 
CaMV35S promoter), pKPFlt-UAS-1X-GUS, pKPFlt-UAS-
2X-GUS and pKFSgt-PFlt-GUS were introduced into Agro-
bacterium tumefaciens strain C58C1 :Pgv3850 by freeze thaw 
method. Tobacco plants (Nicotiana tabacum cv Samsun NN) 
were transformed with the engineered Agrobacterium as 
described earlier (Maiti eta!., 1993). About 10 (ten) indepen-
dent plant lines were generated for each construct. Regener- 15 
ated Kanamycin-resistant plants were grown under green-
house conditions (Temp-28±2° C., humidity-60 to 70%) 
until setting of seed. Seeds were collected from mature plant 
and germinated on Kanamycin antibiotic 300 mg per liter. 
Analysis of GUS Expression in Transgenic Tobacco Plants 
Independent tobacco transgenic lines were developed 
using CaMV35S, PFlt-UAS-1X, PFlt-UAS-2X and FSgt-
PFlt promoter as described earlier. Comparative GUS expres-
sion analyses were conducted using plant leaves (second from 
the top) extract following protocol of Jefferson et a!., 1987. 25 
The result obtained was presented in FIG. 5. Transgenic 
plants expressing the PFlt-UAS-2X and FSgt-PFlt promoter 
showed 1.2 and 2 times stronger activity compared to the 
CaMV 35S promoter. 
20 expression analysis was performed using the corresponding 
eDNA template (1: 15 dilution) and SYBR Premix Ex Takirm 
II (Perfect Real Time, Takara Bio Inc., Japan) employing 
Opticon-2 Real-time PCR machine (MJ Research, Bio-Rad; 
Transgenic plant sections expressing the GUS gene devel-
oped for each constructs were immersed into histochemical 
SEQ. Name of 
NO. Constructs 
6. PF1t-UAS-1X 
(forward) 
7. PF1t-UAS-1X 
(reverse) 
8. PF1t-UAS-2X 
(forward) 
9. PF1t-UAS-2X 
(reverse) 
10. FSgt-PFlt 
(forward) 
11. FSgt-PFlt 
(reverse) 
Model; CFD-3220). Gene specific primers for GUS were 
used at a concentration of 0.8 mmolar to get 95% efficiency. 
The absence of genomic DNA contamination was confirmed 
using minus-reverse-transcriptase controls. The Ct value for 
each reaction was obtained with the help of the software 
attached with the machine and fold changes in the transcript 
levels of each construct (considered for qRT-PCR) were pre-
sented (FIG. 6). 
TABLE 1 
Primer Sequences 
Primer Sequence to amplify 
respective promoter in 5' to 3' direction 
GCGGGCGAATTCGTCAACGAGTTTTTACTTCGGACA 
ATGCAGAAGCTTATGGCCGTGTCTTCTCGA 
GCGGGCGAATTCGTCAACGAGTTTTTACTTCGGACA 
ATGCAGAAGCTTATGGCCGTGTCTTCTCGA 
CCCGAATTCGTCGACTTTACAGTAAGAACTGATAACA 
ATGCAGAAGCTTATGGCCGTGTCTTCTCGA 
12. GUS (real time) GATCGCGAAAACTGTGGAAT 
(forward) 
13. GUS (real time) TAATGAGTGACCGCATCGAA 
(reverse) 
14. Interleukin 2 
(forward) 
15. Interleukin 2 
(reverse) 
GCGGGCTCGAGAACCATGGGTTACAGCATGCAGCTCGCA 
ATGCAGTCTAGATCAGTGATGGTGATGGTGATGTTGAGGGCTTGTTGAGAT 
US 9,322,028 Bl 
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Information for SEQ ID No: 1 (FIG. 1) 
(i) Sequence characteristics: DNA (Genomic) 
(ii) Molecule type: Recombinant DNA 
(iii) Original source: 
(A) Organism: Peanut Chlortic Streak Virus (PClSV) 
**This promoter DNA clone PFlt-UAS-lX is submitted to 
Microbial Type Culture Collection and Gene Bank (MTCC), 
Chandigarh, India under Budapest treaty. 
Information for SEQ ID No: 2 (FIG. 1) 
(iv) Sequence characteristics: DNA (Genomic) 
(v) Molecule type: Recombinant DNA 
(vi) Original source: 
12 
2a) Cloning ofiL-2 in the Protoplast Expression Vector Car-
rying PFlt and MSgt-PFlt Promoter Fragments. 
The 500 bp long IL-2 gene was PCR amplified using spe-
cific primer sequence (Table 2) to incorporate Xho I andXbai 
5 in the 5' and 3' end of the amplified gene respectively. The 
IL-2 gene was cloned into the corresponding sites of the 
protoplast expression vector (Dey and Maiti 1999) by replac-
ing the CaMV35S promoter and the resulting clones were 
designated as pUPPFlt-IL-2 and pUPMSgt-PFlt-IL-2 respec-
10 tively. 
(A) Organism: Peanut Chlortic Streak Virus (PC! SV) 
**This promoter DNA clone PFlt-UAS-2X is being submit-
ted to Microbial Type Culture Collection and Gene Bank 15 
(MTCC), Chandigarh, India under the Budapest treaty. All 
restrictions to the deposit will be revoked upon allowance of 
Example 6 
Transient Assay of the Promoters in Tobacco 
Protoplast System 
Protoplasts from tobacco cell suspension cultures (Xanthi 
'Brad') were purified on 20% sucrose gradient after being a patent covering the subject matter and the deposit will be 
replenished be if needed. 
Information for SEQ ID No: 3 (FIG. 1) 
(vii) Sequence characteristics: DNA (Genomic) 
(viii) Molecule type: Recombinant DNA 
(ix) Original source: 
(A) Organism: Peanut Chlortic Streak Virus (PClSV) and 
Figwort mosaic caulimovirus (FMV). 
**This promoter DNA clone FSgt-PFlt is being submitted to 
Microbial Type Culture Collection and Gene Bank (MTCC), 
Chandigarh, India under the Budapest treaty. All restrictions 
20 digested by cellulase (Sigma Cat #C0615-l G) and pectinase 
(Sigma Cat II P4300-5 KU). Electroporation of protoplasts 
with supercoiled DNA containing GUS reporter genes were 
conducted as described earlier (Kumar eta!., 2012) by using 
the GenePulser II Apparatus (BioRad) with the Capacitance 
25 Extenderii (Model165-2107). In brief, an aliquot of750-0 
containing 2x106 protoplasts in an electroporation cuvette 
(0.4 em electrode gap) was electroporated (200 V used for 
charging 965-f.LF capacitance for 40-50 ms) with 5-f.lg of each 
to the deposit will be revoked upon allowance of a patent 
covering the subject matter and the deposit will be replen- 30 
ished be if needed. 
following promoter constructs CaMV35S, pUPPFlt and 
pUPMSgt-PFlt. 
Transformed protoplast expressing CaMV35S, PFlt and 
MSgt-PFlt were incubated in 1 mM MUG ( 4-methyl-umbel-
lifeiyl-D-glucuronide) at 37° C. for 30 min. to produce MU 
(7-Hydroxy-4-Methylcoumarin) for biochemical GUS esti-
Example 5 
Construction of Vector Containing Modified and 
Chimeric Promoter 
Ia) Cloning of Modified and Chimeric Promoter 
35 
mation (Jefferson eta!., 1987) and the result were presented in 
The 3 7 6 bp long PFlt promoter fragment (-3 52 to + 24) and 
232 bp long MMV-Sgt promoter fragment(~ 356 to -125) 40 
containing UAS domain were PCR amplified as described by 
Dey and Maiti, (1999) using specific primer pairs containing 
the appropriate sequence to generate EcoRI and Hindi sites 
FIG. 11. We observed that pUPMSgt-PFlt promoter showed 
equivalent activity compared to that obtained from 
CaMV35S promoter in tobacco protoplast system. 
To further confirm the reporter gene (GUS) expression, in 
protoplast, we incubated the transformed protoplast express-
ing CaMV35S, PFlt and MSgt-PFlt promoter individually, in 
55 mM ImaGene Green™ C12FDGlcU substrate (ImaGene 
Green™ GUS Gene Expression Kit; Invitrogen, Oregon, at the 5' end and Smai and Hindiii sites at the 3' end using 
corresponding genomic DNA clone. PCR-amplified frag-
ments were restricted with EcoRI and Hindiii endonucleases 
and gel purified. Digested promoter fragments were cloned 
into the corresponding sites of p UC119 vector; the resulting 
plasmids were designated asp UCPFlt promoter fragment and 
pUCMSgt-UAS. All of these plasmids were subjected to 
automated sequencing. The 376 bp long PFlt promoter frag-
ment was isolated from pUCPFlt clone as Hincii-Hindiii 
fragment; and it was then inserted into the Smai and Hindiii 
sites of pUCMSgt-UAS clone. The resulting chimeric pro-
moter clone was designated as MSgt-PFlt. The plasmids were 
sequenced (Sanger et a!., 1977) and the sequence of this 
promoter is presented in FIG. 9. 
1 b) Cloning of MSgt-PFlt Promoter Sequence in the Proto-
plast Expression Vector pUCPMAGUS 
The PFlt promoter fragment and MSgt-PFlt promoter were 
isolated as EcoRI and Hindiii fragments from corresponding 
pUC based clones as discussed above and sub-cloned into the 
corresponding sites of the protoplast expression vector 
coupled to GUS reporter gene p UCPMAGUS (Dey and Maiti 
1999) by replacing the CaMV35S promoter and the resulting 
clones were designated as pUPPFlt and pUPMSgt-PFlt 
respectively. 
45 USA) as per kit's instructions and kept under vacuum infil-
tration for 10 min initially and then incubated at room tem-
perature for 2-3 hrs in the dark. Fluorescence images of 
protoplast, transform with CaMV35S, PFlt promoter frag-
ment and MSgt-PFlt promoter constructs were captured using 
50 a CLSM (TCS SP5; Leica, D 68165 Mannheim, Germany). 
The captured fluorescence images were presented in FIG. 12. 
For estimating GUS, the ImaGene Green™ treated trans-
formed protoplast were excited with 488 diode laser (use of 
495 urn UV laser may be more appropriate) and fluorescence 
55 
emissions were collected between 500 and 515 urn with 
detector (PMT) gain set at 1150V. GUS localizations at cel-
lular/tissue level were detected by green fluorescent lipo-
philic fluorescein derivative (5-dodecanoylaminofluores-
60 cein). 
ELISA of Protoplast Derived IL-2 Protein Driven by PFit 
Promoter Fragment and MSgt-PFlt Promoter Constructs 
A 100 fll PBS containing 10 flg of protein extracts from 
protoplasts transformed with each of PFlt-IL-2 promoter 
65 fragment and MSgt-PFlt-IL-2 constructs were coated into a 
96 well ELISA plate. The concentration of protoplast derived 
IL-2 was estimated following indirect ELISA protocol 
US 9,322,028 Bl 
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(Vazquez eta!., 1996) using an anti-IL-2 antibody (Santacruz, 
USA) and the result obtained is presented in FIG. 15. 
Example 7 
Construction of Plant Expression Vectors with PFlt 
and MSgt-PFlt Promoters, Plant Transformation and 
Analysis of Transgenic Plants 
Promoter fragments PFlt (376 bp) and MSgt-PFlt (614 bp) 10 
were purified from corresponding pUC-clones and were sub-
cloned into the plant expression vector pKYLX71GUS 
(Schardl eta!., 1987; Dey andMaiti 1999) at its uniqueEcoR1 
and Hindiii sites that flank the promoter by replacing the 
CaMV35S promoter. Resulting plant expression vectors were 15 
designated pKPFlt-GUS and pK1 VISgt-PFlt-GUS respec-
tively. 
Promoter constructs namely pKYLX-GUS (containing 
CaMV35S promoter), pKPFlt-GUS and pK1 VISgt-PFlt-
GUS were introduced into Agrobacterium tumefaciens strain 20 
C58C1 :Pgv3850 by freeze thaw method. Tobacco plants 
(Nicotiana tabacum cv Samsun NN) were transformed with 
the engineered Agrobacterium as described earlier (Maiti et 
a!., 1993). About 10 (ten) independent plant lines were gen-
erated for each construct. Regenerated Kanamycin-resistant 25 
plants were grown under greenhouse conditions (Temp-
28±20 C., humidity-60 to 70%) until setting of seed. Seeds 
were collected from mature plant and germinated on Kana-
mycin antibiotic 300 mg per liter. 
Sequence Name of 
No. Constructs 
16. PF1t (forward) 
17. PF1t (reverse) 
18. MSgt-PFlt 
(forward) 
19. MSgt-PFlt 
(reverse) 
14 
5-bromo-4-chloro-3-indolyl-b-D-glucuronide (X -glue), 
vacuum infiltrated under pressure for 10 mM followed by 
incubation at 37° C. overnight. Samples were then washed 
and fixed (in 50% ethanol, 7% acetic acid). The intensity of 
color development in different tissues was monitored and 
photographs were taken by using inverted Leica DM LS2 
microscope at 4x magnification (FIG. 16). 
Example 8 
Reactions of qRT-PCR were performed as described earlier 
by Kumar et a!., 2011. The eDNA was synthesized using 
RNA (DNasei treated) isolated from transgenic tobacco 
plants expressing CaMV35S, PFlt and MSgt-PFlt promoter 
constructs individually using eDNA synthesis Kit (Fermen-
tas, USA). The qRT-PCR for relative expression analysis was 
performed using the corresponding eDNA template (1:15 
dilution) and SYBR Premix Ex Taql'm II (Perfect Real Time, 
Takara Bio Inc., Japan) employing Opticon-2 Real-time PCR 
machine (MJ Research, Bio.-Rad; Model; CFD-3220). Gene 
specific primers for GUS were used at a concentration of0.8 
mmolar to get 95% efficiency. The absence of genomic DNA 
contamination was confirmed using minus-reverse-tran-
scriptase controls. The Ct value for each reaction was 
obtained with the help of the software attached with the 
machine and fold changes in the transcript levels of each 
construct (considered for qRT-PCR) were presented (FIG. 
14). 
TABLE 2 
Primer Se uences 
Primer Sequence to amplify 
respective promoter in 5' to 3' direction 
GCGGGCGAATTCGTCAACGAGTTTTTACTTCGGACA 
ATGCAGAAGCTTATGGCCGTGTCTTCTCGA 
ACTGAATTCGTCGACAGCGGTAAAACAGGTGATTACT 
ATGCAGAAGCTTATGGCCGTGTCTTCTCGA 
12. GUS (real time) GATCGCGAAAACTGTGGAAT 
(forward) 
13. GUS (real time) TAATGAGTGACCGCATCGAA 
(reverse) 
14. 
15. 
Interleukin 2 
(forward) 
Interleukin 2 
(reverse) 
Analysis of GUS Expression in Transgenic Tobacco Plants 55 
Independent tobacco transgenic lines were developed 
using CaMV35S, PFlt and MSgt-PFlt promoters as described 
earlier. Comparative GUS expression analyses were con-
ducted using plant leaf (second from the top) extracts follow-
ing protocol of Jefferson eta!., 1987. The result obtained was 60 
presented in FIG. 13. Transgenic plants expressing the MSgt-
PFlt promoter showed equivalent activity compared to the 
CaMV 35S promoter. 
Transgenic plant sections expressing the GUS gene devel-
oped under each constructs were immersed into histochemi- 65 
cal GUS staining buffer [100 mM NaP04 , 0.5 mM K3 [Fe 
(CN)6 , 0.5 mM K4 [Fe(CN)6 ], 10 mM EDTA, 1 mg/ml 
GCGGGCTCGAGAACCATGGGTTACAGCATGCAGCTCGCA 
ATGCAGTCTAGATCAGTGATGGTGATGGTGATGTTGAGGGCTTGTTGAGAT 
Information for SEQ ID No: 4 (FIG. 9) 
(i) Sequence characteristics: DNA (Genomic) 
(ii) Molecule type: Recombinant DNA 
(iii) Original source: 
(A) Organism: Peanut Chlortic Streak Virus (PC1SV) and 
Mirabilis Mosaic Virus (MMV). 
**This promoter DNA clone MSgt-PFlt is being submitted to 
Microbial Type Culture Collection and Gene Bank (MTCC), 
Chandigarh, India under the Budapest treaty. All restrictions 
to the deposit will be revoked upon allowance of a patent 
covering the subject matter and the deposit will be replen-
ished be if needed. 
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Example 9 
Transient Assay of Recombinant Promoter in 
Arabidopsis Protoplast 
Sterile young leaves of Arabidopsis plants were chopped 
under sterile condition and placed in MS agar media contain-
ing the following supplements: 1 mg/L ofNaphthalene acetic 
acid (NAA), indole-3-acetic acid (IAA), 2,4-Dichlorophe-
noxyacetic acid (2,4-D) and 0.5 mg/L of 6-Benzylaminopu-
rine (BAP). The plates were kept in dark at temperature 24 o C. 
for one month for callus development. Arabidopsis callus 
were shred from plates to 30 ml enzyme solution containing 
2% cellulose and 2% pectinase and incubated in dark at 50 
rpm for 4 hours. After 4 hours, digested Arabidopsis cells 
were passed through a sieve, the flow through was collected 
and centrifuged at 200 g for 5 minutes. The pellet was sus-
pended in 1 ml 0.6 M mannitol and 0.2% CaC12 . Finally, the 
protoplasts were purified over 20% sucrose cushion and 
resuspended in a fresh medium containing 0.6 M mannitol 
and 0.2% CaC12 . The isolated protoplast was counted with the 
help ofhaemocytometer. 
An aliquot of 105 Arabi do psis protoplasts were electropo-
rated with 10 flg plasmid DNA extracted individually from 
pUCPMA (vector control), pUCPMAGUS, PFltGUS, PFlt-
UAS-2XGUS, FSgt-PFltGUS and MSgt-PFltGUS constructs 
following protocol described earlier and fluorimetric GUS 
assay was carried out following standard protocols (Bradford 
1976; Jefferson eta!. 1987). FIG. 17 presented the mean GUS 
activity obtained from four independent experiments for each 
of the above promoter constructs. 
Example 10 
Transient Agro-Infiltration Assay of Chimeric 
Promoters in Solanum lycopersicum, Petunia 
Hybrida and Spinacia oleracea 
16 
old) expressing pKYLXGUS, pKPFltGUS, pKPFlt-UAS-
2XGUS, pKFSgt-PFltGUS and pKMSgt-PFltGUS con-
structs were immersed separately into histochemical GUS 
staining buffer [100 mM NaP04 , 0.5 mM K3 [Fe(CN)6 , 0.5 
5 mM K4 [Fe(CN)6 ], 10 mM EDTA, 1 mg/ml 5-bromo-4-
chloro-3-indolyl-b-D-glucuronide (X-gluc)], vacuum infil-
trated for 10 min followed by incubation at 37° C. for over-
night. Treated samples were subsequently washed and kept in 
fixing solutions (50% ethanol, 7% acetic acid). The intensi-
10 ties of blue color development in different tissues were 
recorded using Leica DM LS2 microscope (Inverted) at lOx 
magnification. (FIG. 19). 
Detailed histochemical expression analysis of the reporter 
gene (GUS) in different sections of floral organs/parts of 
15 transgenic plant expressing pKYLXGUS, pKPFltGUS, pKP-
Flt-UAS-2XGUS, pKFSgt-PFltGUS and pKMSgt-PFltGUS 
constructs was carried out individually in presence of 55 mM 
ImaGene Green™ C12FDGlcU substrate (ImaGene 
Green™ GUS Gene Expression Kit; Invitrogen, Oregon, 
20 USA) as per Kit's instructions. Subsequently, treated samples 
were kept in dark after vacuum infiltration for 10 minutes. 
Fluorescence images of the ImaGene Green™ treated floral 
sections were captured using a CLSM (TCSSP5; Leica, 
D-68165 Mannheim, Germany) and GUS localizations at 
25 cellular/tissue level were detected. (FIG. 20) Intensities of 
green fluorescence obtained from different 50/60 ROis (re-
gions of interest) of transgenic floral organs for individual 
promoter construct were recorded using 'LAS-AF' analytical 
software and average intensity obtained from different floral 
30 organ/tissue were measured (FIG. 21). 
35 
Example 12 
Spatial Distribution of GUS Activities Obtained 
from CaMV35S, CaMV35S2, PFlt, PFlt-UAS-2X, 
FSgt-PFlt and MSgt-PFlt Promoters 
On an average, 8-11 independent plant lines were gener-
Agrobacterium tumefaciens strain C58Cl :pGV3850 was ated for each construct and maintained under standard green-
transformed with pKPFltGUS, pKPFlt-UAS-2XGUS, pKF- 40 house conditions till setting of seeds. Seeds were collected 
Sgt-PFltGUS and pKMSgt-PFltGUS constructs (pKYLX- from each plant line under each construct and germinated on 
GUS based) individually following the freeze thaw method as MS plate supplemented with 300 mg Kanlliter; segregation 
described earlier (Chen et a!. 1994). Agro bacteria lines were analysis for each line was determined (with KanR: Kans=3: 1). 
grown as individual culture as described earlier. Leaves of Kanamycin-resistant seedlings (T 1 generation) under each 
Spinacea oleracea, Petunia hybrida and Solanum lycopersi- 45 construct with appropriate segregation ratio were used for 
cum (var. Samsun NN) were mechanically infused with each further analysis. Leaf, root and stem protein of transgenic 
Agrobacterium constructs individually as described (Imogen seedling (21 days old) expressing above promoter constructs 
et a!. 2006). Quantitative measurements of the GUS activity individually were extracted and the average GUS activity was 
were performed 3-4 days post infusion following standard measured according to the standard protocols (Bradford, 
protocol. FIG. 18 presented the mean GUS activity (obtained 50 1976; Jefferson et a!., 1987). FIG. 22 presented the mean 
from four independent experiments) for each of the promoter promoter activity for each of the promoter construct with 
constructs in above mentioned plant with respective standard respective standard deviation. 
deviations. 
Example 11 
Histochemical Staining of Germinating Seeds, 
Whole Seedlings and Fluorescent Imaging of Floral 
Organs 
Longitudinal cross-sections of germinating seeds express-
ing pKYLXGUS, pKPFltGUS, pKPFlt-UAS-2XGUS, pKF-
Sgt-PFltGUS and pKMSgt-PFltGUS promoter constructs 
individually were performed at different time-points Viz. 0, 
2nd, 4'h and 8'h day of post germination using a Cryostat 
(Modell CM1850-l-1, Leica ). Longitudinal sections of trans-
genic seed and whole seedlings of transgenic plant (21 days 
55 
Example 13 
SA and ABA Treatment 
Transgenic tobacco seeds expressing pKYLX (Control), 
pKYLX, pKYLXGUS, pKYLXGUS35S2 , pKPFltGUS, 
60 pKPFlt-UAS-2XGUS, pKFSgt-PFltGUS and pKMSgt-PFlt-
GUS constructs were germinated on half MS plate (contain-
ing 300 mg/liter Kanamycin) and allowed to grow under 
tissue culture conditions as described earlier (Kumar et a!. 
2012). The whole transgenic seedlings (21 days old) under 
65 each constructs were treated individually in the presence of 
150 f.LM SA (pH 6.8) and ABA (pH 6.8) for a period of0-24 h, 
respectively. 
US 9,322,028 Bl 
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After treatments, GUS activity from SA- andABA-treated 
root, leaf, stem portion of seedlings under each of the above 
mentioned promoter constructs were measured (Bradford 
1976; Jefferson eta!. 1987). The data obtained as a mean of 
four independent experiments in FIG. 9 with respective stan- 5 
dard deviation presented in FIG. 23. 
The following are the accession numbers of your cultures 
deposited in Microbial Type Culture Collection and Gene 
Bank Institute of Microbial Technology (MTCC), Sector 
39-A, Chandigarh-160036, INDIA, under Budapest treaty. 
10 E. coli (TGl)-pUC PF!t-UAS-2X=MTCC 5825 
E. coli (TGl)-pUC FSgt-PF!t=MTCC 5826 
E. coli (TGl)-pUC MSgt-PF!t=MTCC 5827 
It will now be clear that the present invention provides 
features and advantages not found in prior known promoters. 
Further, one of ordinary skill in the art will recognize that 15 
aspects of the present disclosure can be modified using rou-
tine techniques consistent with the present disclosure. 
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-continued 
<400> SEQUENCE, 1 
agtttttact tcggacagtc aaaaatgagt ttaacttctc agccgaggta aaacaagaaa 60 
tatgcttacg tctacagagg gatttctctg aagatcatgt ttgccagcta tgcgaacaat 120 
catcgggaga tcttgagcca atcaaagagg agtgatgtag acctaaagca ataatggagc 180 
catgacgtaa gggcttacgc ccatacgaaa taattaaagg ctgatgtgac ctgtcggtct 240 
ctcagaacct ttacttttta tatttggcgt gtatttttaa atttccacgg caatgacgat 300 
gtgacctgtg catccgcttt gcctataaat aagttttagt ttgtattgat cgacacgatc 360 
gagaagacac ggccat 376 
<210> SEQ ID NO 2 
<211> LENGTH, 686 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, combined promotor from PFlt and UAS 
<400> SEQUENCE, 2 
agtttttact tcggacagtc aaaaatgagt ttaacttctc agccgaggta aaacaagaaa 60 
tatgcttacg tctacagagg gatttctctg aagatcatgt tgccagctat gcgaacaatc 120 
atcgggagat cttgagccaa tcaaagagga gtgatgtaga cctaaagcaa taatggagcc 180 
atgacgtaag ggcttacgcc catacgaaat aattaaaggc tgatgtgacc tgtcggtctc 240 
tcagaacctt tactttttat atttggcgtg tatttttaaa tttccacggc aatgacgagg 300 
tgacccaacg agtttttact tcggacagtc aaaaatgagt ttaacttctc agccgaggta 360 
aaacaagaaa tatgcttacg tctacagagg gatttctctg aagatcatgt ttgccagcaa 420 
tgcgaacaat catcgggaga tcctgagcca atcaaagagg agtgatgtag acctaaagca 480 
ataatggagc catgacgtaa gggcttacgc ccatacgaaa taattaaagg ctgatgtgac 540 
ctgtcggtct ctcagaacct ttacttttta tatttggcgt gtatttttaa atttccacgg 600 
caatgacgat gtggcctgtg catccgcttt gcctataaat aagttttagt ttgtattgat 660 
cgacacgatc gagaagacac ggccat 686 
<210> SEQ ID NO 3 
<211> LENGTH, 593 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, combined promoter clone FSgt and PFl 
<400> SEQUENCE, 3 
ttacagtaag aactgataac aaaaatttta cttatttcct tagaattaat cttaaaggtg 60 
atagtaaaca aggacgatta gtccgttggc aaaattggtt cagcaggtat caatttgatg 120 
tcgaacatct tgaaggtgta aaaaacgttt tagcagattg cctcacgaga gattttaatg 180 
cttaaaaacg taagcgctga cgtatgattt cccaacgagt ttttacttcg gacagtcaaa 240 
aatgagttta acttctcagc cgaggtaaaa caagaaatat gcttacgtct acagagggat 300 
ttctctgaag atcatgtttg ccagcaatgc gaacaatcat cgggagatcc tgagccaatc 360 
aaagaggagt gatgtagacc taaagcaata atggagccat gacgtaaggg cttacgccca 420 
tacgaaataa ttaaaggctg atgtgacctg tcggtctctc agaaccttta ctttttatat 480 
ttggcgtgta tttttaaatt tccacggcaa tgacgatgtg gcctgtgcat ccgctttgcc 540 
tataaataag ttttagtttg tattgatcga cacgatcgag aagacacggc cat 593 
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<210> SEQ ID NO 4 
<211> LENGTH, 614 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, combined promoter clone from MSgt and PFlt 
<400> SEQUENCE, 4 
cggtaaaaca ggtgattact aaatttagta tttatctaac ccctgtttgt tttacagtca 
ggacagataa tgtaaatctt ttaaaaggat ttatgaataa aaagattact ggtgacagta 
aacagggaag gctaataaga tggcaaatgt ggttttcaca ttacaccttt aaggtggacc 
acctaaaagg agaacaaaat gtgctggctg attatctcac cagagaattc ccccaacgag 
tttttacttc ggacagtcaa aaatgagttt aacttctcag ccgaggtaaa acaagaaata 
tgcttacgtc tacagaggga tttctctgaa gatcatgttt gccagcaatg cgaacaatca 
tcgggagatc ctgagccaat caaagaggag tgatgtagac ctaaagcaat aatggagcca 
tgacgtaagg gcttacgccc atacgaaata attaaaggct gatgtgacct gtcggtctct 
cagaaccttt actttttata tttggcgtgt atttttaaat ttccacggca atgacgatgt 
ggcctgtgca tccgctttgc ctataaataa gttttagttt gtattgatcg acacgatcga 
gaagacacgg ccat 
<210> SEQ ID NO 5 
<211> LENGTH, 376 
<212> TYPE, DNA 
<213> ORGANISM, Peanut chlorotic streak virus 
<400> SEQUENCE, 5 
agtttttact tcggacagtc 
tatgcttacg tctacagagg 
catcgggaga tcttgagcca 
catgacgtaa gggcttacgc 
ctcagaacct ttacttttta 
gtgacctgtg catccgcttt 
gagaagacac ggccat 
<210> SEQ ID NO 6 
<211> LENGTH, 36 
<212> TYPE, DNA 
aaaaatgagt ttaacttctc 
gatttctctg aagatcatgt 
atcaaagagg agtgatgtag 
ccatacgaaa taattaaagg 
tatttggcgt gtatttttaa 
gcctataaat aagttttagt 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, promotor sequence 
<400> SEQUENCE, 
gcgggcgaat tcgtcaacga gtttttactt cggaca 
<210> SEQ ID NO 7 
<211> LENGTH, 30 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer sequence 
<400> SEQUENCE, 7 
atgcagaagc ttatggccgt gtcttctcga 
agccgaggta aaacaagaaa 
ttgccagcta tgcgaacaat 
acctaaagca ataatggagc 
ctgatgtgac ctgtcggtct 
atttccacgg caatgacgat 
ttgtattgat cgacacgatc 
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<210> SEQ ID NO 8 
<211> LENGTH, 36 
<212> TYPE, DNA 
23 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer seqeunece 
<400> SEQUENCE, 8 
gcgggcgaat tcgtcaacga gtttttactt cggaca 
<210> SEQ ID NO 9 
<211> LENGTH, 30 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer sequence 
<400> SEQUENCE, 9 
atgcagaagc ttatggccgt gtcttctcga 
<210> SEQ ID NO 10 
<211> LENGTH, 37 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 10 
cccgaattcg tcgactttac agtaagaact gataaca 
<210> SEQ ID NO 11 
<211> LENGTH, 30 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 11 
atgcagaagc ttatggccgt gtcttctcga 
<210> SEQ ID NO 12 
<211> LENGTH, 20 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 12 
gatcgcgaaa actgtggaat 
<210> SEQ ID NO 13 
<211> LENGTH, 20 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 13 
taatgagtga ccgcatcgaa 
<210> SEQ ID NO 14 
<211> LENGTH, 39 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
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<400> SEQUENCE, 14 
gcgggctcga gaaccatggg ttacagcatg cagctcgca 
<210> SEQ ID NO 15 
<211> LENGTH, 51 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 15 
39 
atgcagtcta gatcagtgat ggtgatggtg atgttgaggg cttgttgaga t 51 
<210> SEQ ID NO 16 
<211> LENGTH, 36 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 16 
gcgggcgaat tcgtcaacga gtttttactt cggaca 
<210> SEQ ID NO 17 
<211> LENGTH, 30 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 17 
atgcagaagc ttatggccgt gtcttctcga 
<210> SEQ ID NO 18 
<211> LENGTH, 37 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 18 
actgaattcg tcgacagcgg taaaacaggt gattact 
<210> SEQ ID NO 19 
<211> LENGTH, 30 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 19 
atgcagaagc ttatggccgt gtcttctcga 
The invention claimed is: 
1. An isolated non-naturally occurring DNA molecule, 
comprising a Peanut Chlortic Streak Virus (PClSV) full-
length transcript promoter (Fit) fragment, and a Mirabilis 
Mosaic Virus (MMV) subgenomic transcript promoter (Sgt) 
fragment, comprising the sequence of SEQ ID NO: 4. 
2. The isolated DNA molecule of claim 1, wherein 
the PC! SV full-length transcript promoter fragment com-
prises a fragment between coordinates -353 to +24, and 
55 
36 
30 
37 
30 
the MMV Sgt promoter fragment comprises a fragment 
between coordinates -356 to -125. 
3. The isolated DNA molecule of claim 2, wherein the 
MMV Sgt fragment is ligated to the 5' end of the PClSV Fit 
60 fragment. 
4. The isolated DNA molecule of claim 1, having activity 
that is at least 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 
96, 97, 98, or 99% as compared to the activity of a CaMV35S 
promoter. 
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